Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2003
09/17/2003CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
09/17/2003CN1443239A Compositions and methods for therapy and diagnosis of breast cancer
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443196A Protein complex serving as vehicle for orally administerable medicaments
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/17/2003CN1443077A CD40-binding APC-activating molecules
09/17/2003CN1443076A Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine
09/17/2003CN1443075A Compositions and methods for treatment of candidiasis
09/17/2003CN1442481A PBAD expression system of human source fragment antibody
09/17/2003CN1442479A Mammalian engineering cell line for production of hantan virus granules
09/17/2003CN1442430A AsLc-IFN fusion protein and its preparation
09/17/2003CN1442425A Adjuvent DC-chol, its liposome, preparation method and its use
09/17/2003CN1121239C Anti tumor biological product and preparing method
09/17/2003CN1121224C Pharmaceutical composition comprising compound having anti Xa activity and platelet aggregation antagonist compound
09/16/2003US6620922 Isolated polynucleotide of given sequence; kit
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620913 Polypeptides of a novel hantavirus
09/16/2003US6620795 Expressing an exogenously supplied gene in cells of the airway are disclosed. Lipid carrier-nucleic acid complexes or nucleic acid abre are prepared then delivered via aerosol or systemically to the lung abre or lung plus extrapulmonary
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620618 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines
09/16/2003US6620414 Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
09/16/2003US6620382 Method and compositions for treatment of cancers
09/16/2003CA2145985C Vascular endothelial cell growth factor antagonists
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/12/2003WO2003074712A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074687A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003WO2003074682A1 Bacterial spores
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074568A1 Individualized anti-cancer antibodies
09/12/2003WO2003074565A2 Peptides for use in antitumor immunotherapy
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074555A2 Synthetic peptides from c. difficile
09/12/2003WO2003074552A1 An infectious bursal disease virus variant
09/12/2003WO2003074543A1 Anti-protozoal vaccine
09/12/2003WO2003074087A1 Coupling proteins to a modified polysaccharide
09/12/2003WO2003074081A1 SPECIFIC ANTIBODIES TO AMYLOID β PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074079A1 Solidified tissue immunological adjuvant
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074004A2 Method of producing antigens
09/12/2003WO2003074003A2 Immunogens for treatment of neoplastic and infectious disease
09/12/2003WO2003074000A2 Eleutherosides as adjuncts for vaccines and immune modulation
09/12/2003WO2003073994A2 Methods of treating nerve entrapment syndromes
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073981A2 Novel of cytokine inhibitors
09/12/2003WO2003073918A2 Prevention of recurrence and metastasis of cancer
09/12/2003WO2003073916A2 Immune regulation
09/12/2003WO2003073828A2 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003061558A3 Glycoconjugate vaccines for use in immune-compromised populations
09/12/2003WO2003048371A3 Dna vaccine
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same
09/12/2003WO2002083077A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002080966A3 Method for producing a vaccine containing autologous antibodies
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002058727A3 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002040059A3 Methods and compositions for inducing cell-mediated immune responses
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects
09/12/2003WO2002028362A3 Vaccine composition and stabilisation method
09/12/2003WO2002010401A9 18431 and 32374, human protein kinase family members and uses therefor
09/12/2003WO2001088200A3 Isolation of genes within sle-1b taht mediate a beak in immune tolerance
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478378A1 Novel use of cytokine inhibitors
09/12/2003CA2478106A1 Solidified tissue immunoadjuvant
09/12/2003CA2477808A1 Methods of treating nerve entrapment syndromes
09/12/2003CA2477794A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2477762A1 Peptides for use in antitumor immunotherapy
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477647A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
09/12/2003CA2477406A1 Dna vaccine against proliferating endothelial cells and methods of use thereof
09/12/2003CA2476724A1 Prevention of recurrence and metastasis of cancer
09/12/2003CA2476182A1 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
09/12/2003CA2456077A1 Individualized anti-cancer antibodies
09/11/2003WO2003074551A2 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
09/11/2003WO2003073995A2 Dna vaccine against proliferating endothelial cells and methods of use thereof.
09/11/2003US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy
09/11/2003US20030171567 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
09/11/2003US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171552 A single-chain T-cell receptor covalently linked to single-chain antibody; anticarcinogenic agents for treating cancer
09/11/2003US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171546 Chimeric immunoreceptor useful in treating human cancers
09/11/2003US20030171542 Mammalian secretory peptide - 9
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171538 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/11/2003US20030171334 Treatment of prostate cancer
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171321 Immunostimulatory oligodeoxynucleotides